D1-DOPAMINE AND D2-DOPAMINE BINDING-SITE UP-REGULATION AND APOMORPHINE-INDUCED STEREOTYPY

被引:49
作者
CHIPKIN, RE
MCQUADE, RD
IORIO, LC
机构
关键词
D O I
10.1016/0091-3057(87)90509-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:477 / 482
页数:6
相关论文
共 23 条
[2]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[3]   SCH-23390 MAY ALTER DOPAMINE-MEDIATED MOTOR BEHAVIOR VIA STRIATAL D-1 RECEPTORS [J].
BOYCE, S ;
KELLY, E ;
DAVIS, A ;
FLEMINGER, S ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (10) :1665-1669
[4]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[5]   DETECTION OF NEUROLEPTIC PROPERTIES OF CLOZAPINE, SULPIRIDE AND THIORIDAZINE [J].
COSTALL, B ;
NAYLOR, RJ .
PSYCHOPHARMACOLOGIA, 1975, 43 (01) :69-74
[6]   SELECTIVE D-1 DOPAMINE RECEPTOR INCREASE FOLLOWING CHRONIC TREATMENT WITH SCH 23390 [J].
CREESE, I ;
CHEN, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 109 (01) :127-128
[7]  
FINNEY DJ, 1952, STATISTICAL METHODS
[8]  
Goetz C G, 1983, Mod Probl Pharmacopsychiatry, V21, P5
[9]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[10]  
HEMMINGS HC, 1984, J BIOL CHEM, V259, P4486